Top compounds associated with response to TTLL2


Feature Type Standardized
Nominal ANOVA
mRNA TAE684 CTRPv2 pan-cancer AAC 0.19 1e-07
mRNA CHEMBL1222381 CTRPv2 pan-cancer AAC 0.17 2e-07
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.17 2e-06
mRNA BRD-K28456706 CTRPv2 pan-cancer AAC 0.17 3e-06
mRNA CCT036477 CTRPv2 pan-cancer AAC 0.16 3e-06
mRNA BMS-754807 CTRPv2 pan-cancer AAC 0.16 4e-06
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.14 9e-06
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.16 1e-05
mRNA VU0155056 CTRPv2 pan-cancer AAC 0.17 1e-05
mRNA ciclosporin CTRPv2 pan-cancer AAC 0.17 1e-05
Download CSV